The latest study on Oncology Biosimilars Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2026. The global Oncology Biosimilars market size is estimated at XXX million USD with a CAGR XX% from 2016-2020 and is expected to reach XXX Million USD in 2021 with a CAGR XX% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Flannel by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Oncology Biosimilars Market Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
G-CSF
Hematopoietic Agents
Monoclonal Antibodies
Oncology Biosimilars Market Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Celltrion Inc.
Pfizer Inc.
Biocon
BIOCAD
Apotex Inc.
Dr. Reddy's
Sandoz International GmbH
Intas Pharmaceuticals Ltd.
STADA Arzneimittel AG
Teva Pharmaceutical Industries Ltd
Oncology Biosimilars Market Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Oncology Biosimilars Market Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Competitive Landscape of Oncology Biosimilars Market:
Oncology Biosimilars market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
Detailed information about Key Top Competitors in the Global Oncology Biosimilars Market
What is the expected Market size and growth rate of the Oncology Biosimilars market for the forecast period
Where is the largest and fastest growing market for Oncology Biosimilars market
How does the market relate to the overall economy, demography and other similar markets
What forces will shape the market going forward
Can I include additional segmentation / market segmentation
Oncology Biosimilars market global report answers all these questions and many more.
The study objectives are:
To analyze and research the Oncology Biosimilars Market status and future forecast.
To present the key Oncology Biosimilars Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Industry Overview
1.1 Oncology Biosimilars Industry
Figure Oncology Biosimilars Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Oncology Biosimilars
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Oncology Biosimilars
1.2.2 Downstream
Table Application Segment of Oncology Biosimilars
Table Global Oncology Biosimilars Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Oncology Biosimilars Market by Type
3.1 By Type
3.1.1 G-CSF
Table Major Company List of G-CSF
3.1.2 Hematopoietic Agents
Table Major Company List of Hematopoietic Agents
3.1.3 Monoclonal Antibodies
Table Major Company List of Monoclonal Antibodies
3.2 Market Size
Table Global Oncology Biosimilars Market 2016-2020, by Type, in USD Million
Figure Global Oncology Biosimilars Market Growth 2016-2020, by Type, in USD Million
Table Global Oncology Biosimilars Market 2016-2020, by Type, in Volume
Figure Global Oncology Biosimilars Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Oncology Biosimilars Market Forecast 2021-2026, by Type, in USD Million
Table Global Oncology Biosimilars Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Celltrion Inc. (Company Profile, Sales Data etc.)
4.1.1 Celltrion Inc. Profile
Table Celltrion Inc. Overview List
4.1.2 Celltrion Inc. Products & Services
4.1.3 Celltrion Inc. Business Operation Conditions
Table Business Operation of Celltrion Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Pfizer Inc. (Company Profile, Sales Data etc.)
4.2.1 Pfizer Inc. Profile
Table Pfizer Inc. Overview List
4.2.2 Pfizer Inc. Products & Services
4.2.3 Pfizer Inc. Business Operation Conditions
Table Business Operation of Pfizer Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Biocon (Company Profile, Sales Data etc.)
4.3.1 Biocon Profile
Table Biocon Overview List
4.3.2 Biocon Products & Services
4.3.3 Biocon Business Operation Conditions
Table Business Operation of Biocon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 BIOCAD (Company Profile, Sales Data etc.)
4.4.1 BIOCAD Profile
Table BIOCAD Overview List
4.4.2 BIOCAD Products & Services
4.4.3 BIOCAD Business Operation Conditions
Table Business Operation of BIOCAD (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Apotex Inc. (Company Profile, Sales Data etc.)
4.5.1 Apotex Inc. Profile
Table Apotex Inc. Overview List
4.5.2 Apotex Inc. Products & Services
4.5.3 Apotex Inc. Business Operation Conditions
Table Business Operation of Apotex Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Dr. Reddy's (Company Profile, Sales Data etc.)
4.6.1 Dr. Reddy's Profile
Table Dr. Reddy's Overview List
4.6.2 Dr. Reddy's Products & Services
4.6.3 Dr. Reddy's Business Operation Conditions
Table Business Operation of Dr. Reddy's (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Sandoz International GmbH (Company Profile, Sales Data etc.)
4.7.1 Sandoz International GmbH Profile
Table Sandoz International GmbH Overview List
4.7.2 Sandoz International GmbH Products & Services
4.7.3 Sandoz International GmbH Business Operation Conditions
Table Business Operation of Sandoz International GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Intas Pharmaceuticals Ltd. (Company Profile, Sales Data etc.)
4.8.1 Intas Pharmaceuticals Ltd. Profile
Table Intas Pharmaceuticals Ltd. Overview List
4.8.2 Intas Pharmaceuticals Ltd. Products & Services
4.8.3 Intas Pharmaceuticals Ltd. Business Operation Conditions
Table Business Operation of Intas Pharmaceuticals Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 STADA Arzneimittel AG (Company Profile, Sales Data etc.)
4.9.1 STADA Arzneimittel AG Profile
Table STADA Arzneimittel AG Overview List
4.9.2 STADA Arzneimittel AG Products & Services
4.9.3 STADA Arzneimittel AG Business Operation Conditions
Table Business Operation of STADA Arzneimittel AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Teva Pharmaceutical Industries Ltd (Company Profile, Sales Data etc.)
4.10.1 Teva Pharmaceutical Industries Ltd Profile
Table Teva Pharmaceutical Industries Ltd Overview List
4.10.2 Teva Pharmaceutical Industries Ltd Products & Services
4.10.3 Teva Pharmaceutical Industries Ltd Business Operation Conditions
Table Business Operation of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Oncology Biosimilars Sales Revenue 2016-2020, by Company, in USD Million
Table Global Oncology Biosimilars Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Oncology Biosimilars Sales Revenue Share in 2020, by Company, in USD Million
Table Global Oncology Biosimilars Sales Volume 2016-2020, by Company, in Volume
Table Global Oncology Biosimilars Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Oncology Biosimilars Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Oncology Biosimilars Market Concentration, in 2020
Figure Europe Oncology Biosimilars Market Market Concentration, in 2020
Figure Asia-Pacific Oncology Biosimilars MMarket Concentration, in 2020
Figure South America Oncology Biosimilars Market Concentration, in 2020
Figure Middle East & Africa Oncology Biosimilars Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Retail Pharmacies
Figure Oncology Biosimilars Demand in Retail Pharmacies, 2016-2020, in USD Million
Figure Oncology Biosimilars Demand in Retail Pharmacies, 2016-2020, in Volume
6.1.2 Demand in Hospital Pharmacies
Figure Oncology Biosimilars Demand in Hospital Pharmacies, 2016-2020, in USD Million
Figure Oncology Biosimilars Demand in Hospital Pharmacies, 2016-2020, in Volume
6.1.3 Demand in Online Pharmacies
Figure Oncology Biosimilars Demand in Online Pharmacies, 2016-2020, in USD Million
Figure Oncology Biosimilars Demand in Online Pharmacies, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Oncology Biosimilars Demand Forecast 2021-2026, by Application, in USD Million
Figure Oncology Biosimilars Market Growth 2021-2026, by Application, in USD Million
Figure Oncology Biosimilars Market Share in 2026, by Application, in USD Million
Table Oncology Biosimilars Demand Forecast 2021-2026, by Application, in Volume
Table Oncology Biosimilars Market Growth 2021-2026, by Application, in Volume
Table Oncology Biosimilars Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Oncology Biosimilars Production 2016-2020, by Region, in USD Million
Table Oncology Biosimilars Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Oncology Biosimilars Market 2016-2020, by Region, in USD Million
Table Global Oncology Biosimilars Market Share 2016-2020, by Region, in USD Million
Table Global Oncology Biosimilars Market 2016-2020, by Region, in Volume
Table Global Oncology Biosimilars Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Oncology Biosimilars Market Size and Growth 2016-2020, in USD Million
Figure North America Oncology Biosimilars Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Oncology Biosimilars Market Size 2016-2020, by Country, in USD Million
Table North America Oncology Biosimilars Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Oncology Biosimilars Market Size and Growth 2016-2020, in USD Million
Figure Europe Oncology Biosimilars Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Oncology Biosimilars Market Size 2016-2020, by Country, in USD Million
Table Europe Oncology Biosimilars Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Oncology Biosimilars Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Oncology Biosimilars Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Oncology Biosimilars Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Oncology Biosimilars Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Oncology Biosimilars Market Size and Growth 2016-2020, in USD Million
Figure South America Oncology Biosimilars Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Oncology Biosimilars Market Size 2016-2020, by Country, in USD Million
Table South America Oncology Biosimilars Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Oncology Biosimilars Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Oncology Biosimilars Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Oncology Biosimilars Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Oncology Biosimilars Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Oncology Biosimilars Market Forecast 2021-2026, by Region, in USD Million
Table Oncology Biosimilars Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Tables and Figures
List of Table
1. Table Upstream Segment of Oncology Biosimilars
2. Table Application Segment of Oncology Biosimilars
3. Table Global Oncology Biosimilars Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Hematopoietic Agents
5. Table Major Company List of Monoclonal Antibodies
6. Table Global Oncology Biosimilars Market 2016-2020, by Type, in USD Million
7. Table Global Oncology Biosimilars Market 2016-2020, by Type, in Volume
8. Table Global Oncology Biosimilars Market Forecast 2021-2026, by Type, in USD Million
9. Table Global Oncology Biosimilars Market Forecast 2021-2026, by Type, in Volume
10. Table Celltrion Inc. Overview List
11. Table Business Operation of Celltrion Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
12. Table Pfizer Inc. Overview List
13. Table Business Operation of Pfizer Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
14. Table Biocon Overview List
15. Table Business Operation of Biocon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
16. Table BIOCAD Overview List
17. Table Business Operation of BIOCAD (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
18. Table Apotex Inc. Overview List
19. Table Business Operation of Apotex Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
20. Table Dr. Reddy's Overview List
21. Table Business Operation of Dr. Reddy's (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
22. Table Sandoz International GmbH Overview List
23. Table Business Operation of Sandoz International GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
24. Table Intas Pharmaceuticals Ltd. Overview List
25. Table Business Operation of Intas Pharmaceuticals Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
26. Table STADA Arzneimittel AG Overview List
27. Table Business Operation of STADA Arzneimittel AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
28. Table Teva Pharmaceutical Industries Ltd Overview List
29. Table Business Operation of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
30. Table Global Oncology Biosimilars Sales Revenue 2016-2020, by Company, in USD Million
31. Table Global Oncology Biosimilars Sales Revenue Share 2016-2020, by Company, in USD Million
32. Table Global Oncology Biosimilars Sales Volume 2016-2020, by Company, in Volume
33. Table Global Oncology Biosimilars Sales Volume Share 2016-2020, by Company, in Volume
34. Table Regional Demand Comparison List
35. Table Major Application in Different Regions
36. Table Oncology Biosimilars Demand Forecast 2021-2026, by Application, in USD Million
37. Table Oncology Biosimilars Demand Forecast 2021-2026, by Application, in Volume
38. Table Oncology Biosimilars Market Growth 2021-2026, by Application, in Volume
39. Table Oncology Biosimilars Market Share in 2026, by Application, in Volume
40. Table Oncology Biosimilars Production 2016-2020, by Region, in USD Million
41. Table Oncology Biosimilars Production 2016-2020, by Region, in Volume
42. Table Global Oncology Biosimilars Market 2016-2020, by Region, in USD Million
43. Table Global Oncology Biosimilars Market Share 2016-2020, by Region, in USD Million
44. Table Global Oncology Biosimilars Market 2016-2020, by Region, in Volume
45. Table Global Oncology Biosimilars Market Share 2016-2020, by Region, in Volume
46. Table North America Oncology Biosimilars Market Size 2016-2020, by Country, in USD Million
47. Table North America Oncology Biosimilars Market Size 2016-2020, by Country, in Volume
48. Table Europe Oncology Biosimilars Market Size 2016-2020, by Country, in USD Million
49. Table Europe Oncology Biosimilars Market Size 2016-2020, by Country, in Volume
50. Table Asia-Pacific Oncology Biosimilars Market Size 2016-2020, by Country, in USD Million
51. Table Asia-Pacific Oncology Biosimilars Market Size 2016-2020, by Country, in Volume
52. Table South America Oncology Biosimilars Market Size 2016-2020, by Country, in USD Million
53. Table South America Oncology Biosimilars Market Size 2016-2020, by Country, in Volume
54. Table Middle East & Africa Oncology Biosimilars Market Size 2016-2020, by Country, in USD Million
55. Table Middle East & Africa Oncology Biosimilars Market Size 2016-2020, by Country, in Volume
56. Table Oncology Biosimilars Market Forecast 2021-2026, by Region, in USD Million
57. Table Oncology Biosimilars Market Forecast 2021-2026, by Region, in Volume
58. Table Price Factors List
List of Figure
1. Figure Oncology Biosimilars Industry Chain Structure
2. Figure Global Oncology Biosimilars Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Oncology Biosimilars Market Growth 2016-2020, by Type, in Volume
4. Figure Global Oncology Biosimilars Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Oncology Biosimilars Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Oncology Biosimilars Market Concentration, in 2020
7. Figure Europe Oncology Biosimilars Market Market Concentration, in 2020
8. Figure Asia-Pacific Oncology Biosimilars MMarket Concentration, in 2020
9. Figure South America Oncology Biosimilars Market Concentration, in 2020
10. Figure Middle East & Africa Oncology Biosimilars Market Concentration, in 2020
11. Figure Oncology Biosimilars Demand in Retail Pharmacies, 2016-2020, in USD Million
12. Figure Oncology Biosimilars Demand in Retail Pharmacies, 2016-2020, in Volume
13. Figure Oncology Biosimilars Demand in Hospital Pharmacies, 2016-2020, in USD Million
14. Figure Oncology Biosimilars Demand in Hospital Pharmacies, 2016-2020, in Volume
15. Figure Oncology Biosimilars Demand in Online Pharmacies, 2016-2020, in USD Million
16. Figure Oncology Biosimilars Demand in Online Pharmacies, 2016-2020, in Volume
17. Figure Oncology Biosimilars Market Growth 2021-2026, by Application, in USD Million
18. Figure Oncology Biosimilars Market Share in 2026, by Application, in USD Million
19. Figure North America Oncology Biosimilars Market Size and Growth 2016-2020, in USD Million
20. Figure North America Oncology Biosimilars Market Size and Growth 2016-2020, in Volume
21. Figure Europe Oncology Biosimilars Market Size and Growth 2016-2020, in USD Million
22. Figure Europe Oncology Biosimilars Market Size and Growth 2016-2020, in Volume
23. Figure Asia-Pacific Oncology Biosimilars Market Size and Growth 2016-2020, in USD Million
24. Figure Asia-Pacific Oncology Biosimilars Market Size and Growth 2016-2020, in Volume
25. Figure South America Oncology Biosimilars Market Size and Growth 2016-2020, in USD Million
26. Figure South America Oncology Biosimilars Market Size and Growth 2016-2020, in Volume
27. Figure Middle East & Africa Oncology Biosimilars Market Size and Growth 2016-2020, in USD Million
28. Figure Middle East & Africa Oncology Biosimilars Market Size and Growth 2016-2020, in Volume
29. Figure Marketing Channels Overview